These included CD40, TRAF1, EBI3, and ICAM1 (Fig. 4A), which were previously established as TES1 target genes in studies of cell lines overexpressing LMP1, including BL-41 Burkitt and BJAB diffuse large B-cell lymphoma models (55). This evidence concerns the gene DLX2 and diffuse large B-cell lymphoma.